Susquehanna International Group
CRL icon

Susquehanna International Group’s Charles River Laboratories CRL Stock Holding History

Susquehanna International Group’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.54M Buy
43,700
+12,900
+42% +$2.39M ﹤0.01% 3539
2025
Q4 		$6.14M Sell
30,800
-73,100
-70% -$13.3M ﹤0.01% 3711
2025
Q3 		$16.3M Sell
103,900
-19,200
-16% -$3.05M ﹤0.01% 2425
2025
Q2 		$18.7M Buy
123,100
+14,500
+13% +$1.93M ﹤0.01% 2083
2025
Q1 		$16.3M Sell
108,600
-600
-0.5% -$101K ﹤0.01% 1942
2024
Q4 		$20.2M Sell
109,200
-49,600
-31% -$9.55M ﹤0.01% 1852
2024
Q3 		$31.3M Buy
158,800
+81,000
+104% +$16.8M 0.01% 1437
2024
Q2 		$16.1M Buy
77,800
+200
+0.3% +$45.3K ﹤0.01% 1965
2024
Q1 		$21M Buy
77,600
+14,500
+23% +$3.46M ﹤0.01% 1733
2023
Q4 		$14.9M Sell
63,100
-30,700
-33% -$6.04M ﹤0.01% 2131
2023
Q3 		$18.4M Buy
93,800
+34,700
+59% +$7.12M ﹤0.01% 1834
2023
Q2 		$12.4M Buy
59,100
+5,700
+11% +$1.13M ﹤0.01% 2252
2023
Q1 		$10.8M Sell
53,400
-32,300
-38% -$7.32M ﹤0.01% 2342
2022
Q4 		$18.7M Buy
85,700
+64,100
+297% +$14M ﹤0.01% 1590
2022
Q3 		$4.25M Sell
21,600
-29,700
-58% -$6.41M ﹤0.01% 3419
2022
Q2 		$11M Sell
51,300
-20,700
-29% -$5.06M ﹤0.01% 2084
2022
Q1 		$20.4M Buy
72,000
+31,200
+76% +$9.62M ﹤0.01% 1712
2021
Q4 		$15.4M Buy
40,800
+5,400
+15% +$2.1M ﹤0.01% 2142
2021
Q3 		$14.6M Sell
35,400
-36,900
-51% -$15.3M ﹤0.01% 2347
2021
Q2 		$26.7M Buy
72,300
+18,100
+33% +$6.04M ﹤0.01% 1721
2021
Q1 		$15.7M Buy
54,200
+4,400
+9% +$1.22M ﹤0.01% 2179
2020
Q4 		$12.4M Buy
49,800
+27,600
+124% +$6.57M ﹤0.01% 2247
2020
Q3 		$5.03M Sell
22,200
-56,100
-72% -$11.6M ﹤0.01% 3037
2020
Q2 		$13.7M Buy
78,300
+58,500
+295% +$9.34M ﹤0.01% 1797
2020
Q1 		$2.5M Sell
19,800
-7,700
-28% -$1.15M ﹤0.01% 3580
2019
Q4 		$4.2M Buy
27,500
+15,500
+129% +$2.15M ﹤0.01% 3226
2019
Q3 		$1.59M Buy
12,000
+300
+3% +$40.2K ﹤0.01% 4682
2019
Q2 		$1.66M Sell
11,700
-23,600
-67% -$3.2M ﹤0.01% 4544
2019
Q1 		$5.13M Buy
35,300
+33,100
+1,505% +$4.35M ﹤0.01% 2417
2018
Q4 		$249K Buy
+2,200
New +$275K ﹤0.01% 7349
2018
Q3 		– Sell
-4,300
Closed -$483K – 9326
2018
Q2 		$483K Sell
4,300
-15,900
-79% -$1.72M ﹤0.01% 6861
2018
Q1 		$2.16M Buy
20,200
+7,900
+64% +$852K ﹤0.01% 3774
2017
Q4 		$1.35M Buy
12,300
+8,100
+193% +$881K ﹤0.01% 4647
2017
Q3 		$454K Buy
+4,200
New +$431K ﹤0.01% 6679
2017
Q2 		– Sell
-2,300
Closed -$207K – 9258
2017
Q1 		$207K Sell
2,300
-3,900
-63% -$331K ﹤0.01% 7948
2016
Q4 		$472K Sell
6,200
-3,300
-35% -$251K ﹤0.01% 7117
2016
Q3 		$792K Buy
9,500
+5,900
+164% +$495K ﹤0.01% 5229
2016
Q2 		$297K Sell
3,600
-10,000
-74% -$824K ﹤0.01% 6970
2016
Q1 		$1.03M Buy
13,600
+4,600
+51% +$341K ﹤0.01% 5024
2015
Q4 		$724K Sell
9,000
-1,500
-14% -$108K ﹤0.01% 6065
2015
Q3 		$667K Buy
+10,500
New +$754K ﹤0.01% 6560
2015
Q1 		– Sell
-3,400
Closed -$216K – 9458
2014
Q4 		$216K Sell
3,400
-2,500
-42% -$157K ﹤0.01% 8676
2014
Q3 		$352K Buy
+5,900
New +$338K ﹤0.01% 7779
2014
Q2 		– Sell
-4,600
Closed -$278K – 9787
2014
Q1 		$278K Sell
4,600
-3,800
-45% -$222K ﹤0.01% 7702
2013
Q4 		$446K Sell
8,400
-1,400
-14% -$70.3K ﹤0.01% 6906
2013
Q3 		$453K Sell
9,800
-17,100
-64% -$785K ﹤0.01% 6577
2013
Q2 		$1.1M Buy
+26,900
New +$1.15M ﹤0.01% 4832

Other funds holding CRL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Susquehanna International Group's CRL Position: Q1 2026 in Review

Susquehanna International Group reduced its Charles River Laboratories (CRL) stake by 20% in Q1 2026, selling an estimated $874K and leaving 18,995 shares worth $3.28M. The position accounts for ﹤0.01% of the portfolio, ranked #5093.

Susquehanna International Group first reported a position in CRL in Q2 2013 and has held it in 39 quarters since. The position peaked at $13.3M in Q4 2021. 558 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

  • Susquehanna International Group held 18,995 shares of Charles River Laboratories worth $3.28M as of Q1 2026.
  • Susquehanna International Group sold 4,712 Charles River Laboratories shares in Q1 2026, an estimated $874K.
  • Charles River Laboratories made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #5093 holding.
  • Susquehanna International Group first reported a position in Charles River Laboratories in Q2 2013 and has held it in 39 quarters since.
  • Susquehanna International Group's Charles River Laboratories position peaked at $13.3M in Q4 2021.
  • 558 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.